Halozyme Therapeutics competitorsClear all

Agenus's top competitors include Blueprint Medicines and Karyopharm Therapeutics.

	Agenus Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.	Blueprint Medicines Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.	Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Founding Date	Founding Date 1994	Founding Date 2011	Founding Date 2008
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research drug development oncology pharma platform therapy	Tags Healthcare drug development life sciences oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Lexington, US HQ Cambridge, GB Berkeley, US New York, US	Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH Cambridge, US	Locations Newton, US HQ München, DE Giv'atayim, IL Providence, US
Employees	Employees 32812% increase	Employees 38376% increase	Employees 4822% decrease
Valuation ($)	Valuation ($) 418.6 m	Valuation ($) 3.3 b	Valuation ($) N/A
Twitter followers	Twitter followers 2.3 k	Twitter followers 2.6 k	Twitter followers N/A
Number of tweets (last 30 days)	Number of tweets (last 30 days) 3	Number of tweets (last 30 days) 15	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 7	Average likes per tweet (last 30 days) 3.9	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 86.67%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 155568	Alexa Website Rank 182678	Alexa Website Rank 230559
Employee Rating	Employee Rating 3.3	Employee Rating N/A	Employee Rating 3.5
Financial
Revenue (est.)	Revenue (est.) $88.2m (FY, 2020)	Revenue (est.) $793.7m (FY, 2020)	Revenue (est.) $108.1m (FY, 2020)
Cost of goods	Cost of goods $2.3m (FY, 2020)	Cost of goods $425k (FY, 2020)	Cost of goods N/A
Gross profit	Gross profit $85.8m (FY, 2020)	Gross profit $793.3m (FY, 2020)	Gross profit N/A
Net income	Net income ($182.9m) (FY, 2020)	Net income $313.9m (FY, 2020)	Net income ($196.3m) (FY, 2020)
Funding
Total funding raised	Total funding raised $ 171.1m	Total funding raised $ 115m	Total funding raised $ 248.7m